Severe Hypoglycemia Is Associated With Antidiabetic Oral Treatment Compared With Insulin Analogs in Nursing Home Patients With Type 2 Diabetes and Dementia: Results From the DIMORA Study

Journal of the American Medical Directors Association

Volumn 16, Issue 4, 2015, Pages 349.e7-349.e12

  Abbatecola, Angela Marie ^a   Bo, Mario ^b   Barbagallo, Mario ^c   Incalzi, Raffaele Antonelli ^d   Pilotto, Alberto ^e   Bellelli, Giuseppe ^f,g,h   Maggi, Stefania ⁱ   Paolisso, Giuseppe ^j  

^a Italian Society of Gerontology and Geriatrics (SIGG)   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^e Hospital Sant Antonio   (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g SAN GERARDO HOSPITAL   (Italy)

^h NeuroMi Milan Center for Neuroscience   (Italy)

ⁱ CNR   (Italy)

^j SECOND UNIVERSITY OF NAPLES   (Italy)

more..

Author keywords

Aging; Antidiabetic oral agents; Dementia; Insulin analogs; Severe hypoglycemia

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIC AGENT; INSULIN; SULFONYLUREA DERIVATIVE;

AGE DISTRIBUTION; AGED; ANALYSIS; BLOOD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DEMENTIA; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FEMALE; GLUCOSE BLOOD LEVEL; HOME FOR THE AGED; HUMAN; HYPOGLYCEMIA; ITALY; MALE; MIDDLE AGED; NURSING HOME; ODDS RATIO; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX RATIO; STATISTICAL MODEL; VERY ELDERLY;

ADMINISTRATION, ORAL; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DEMENTIA; DIABETES MELLITUS, TYPE 2; FEMALE; HOMES FOR THE AGED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN ANTAGONISTS; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; NURSING HOMES; ODDS RATIO; PREVALENCE; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SULFONYLUREA COMPOUNDS;

EID: 84934438765     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.12.014     Document Type: Article

References (28)

1. Feinkohl I., Aung P.P., Keller M., et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: The Edinburgh type 2 diabetes study. Diabetes Care 2014, 37:507-515. Edinburgh Type 2 Diabetes Study (ET2DS) Investigators.
2. Bruce D.G., Davis W.A., Casey G.P., et al. Severe hypoglycaemia and cognitive impairment in older patients with diabetes: The Fremantle Diabetes Study. Diabetologia 2009, 52:1808-1815.
3. Bruce D.G., Davis W.A., Casey G.P., et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 2008, 51:241-248.
4. Bree A.J., Puente E.C., Daphna-Iken D., Fisher S.J. Diabetes increases brain damage caused by severe hypoglycemia. Am J Physiol Endocrinol Metab 2009, 297:E194-E201.
5. Bauduceau B., Doucet J., Bordier L., et al. Hypoglycaemia and dementia in diabetic patients. Diabetes Metab 2010, 36:S106-S111.
6. Basso A., Peruzzi P., Carollo M.C., et al. Assessment of glycemic control among diabetic residents in nursing homes. Diabetes Res Clin Pract 2012, 96:e80-e83.
7. Brown A.F., Mangione C.M., Saliba D., Sarkisian C.A. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. JAm Geriatr Soc 2003, 51:S265-S280.
8. Inzucchi S.E., Bergenstal R.M., Buse J.B., et al. Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012, 55:1577-1596.
9. Sinclair A.J., Paolisso G., Castro M., et al. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011, 37:S27-S38. European Diabetes Working Party for Older People.
10. Sinclair A.J. Good clinical practice guidelines for care home residents with diabetes: An executive summary. Diabet Med 2011, 28:772-777. Task and Finish Group of Diabetes UK.
11. American Geriatrics Society identifies another five things that healthcare providers and patients should question. JAm Geriatr Soc 2014, 62:950-960. AGS Choosing Wisely Workgroup.
12. DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Text revision, American Psychiatric Association, Washington, DC. 4th ed.
13. Katz S., Ford A.B., Moskowitz R.W., et al. Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychological function. JAMA 1963, 185:914-919.
14. Greco D., Pisciotta M., Gambina F., Maggio F. Severe hypoglycaemia leading to hospital admission in type 2 diabetic patients aged 80 years or older. Exp Clin Endocrinol Diabetes 2010, 118:215-219.
15. Punthakee Z., Miller M.E., Launer L.J., et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 2012, 35:787-793. ACCORD Group of Investigators; ACCORD-MIND Investigators.
16. Lu F.P., Lin K.P., Kuo H.K. Diabetes and the risk of multi-system aging phenotypes: A systematic review and meta-analysis. PLoS One 2009, 4:e4144.
17. Yaffe K., Falvey C.M., Hamilton N., et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013, 173:1300-1306. Health ABC Study.
18. Cox D., Gonder-Frederick L., McCall A., et al. The effects of glucose fluctuation on cognitive function and QOL: The functional costs of hypoglycaemia and hyperglycaemia among adults with type 1 or type 2 diabetes. Int J Clin Pract Suppl 2002, 129:20-26.
19. Abbatecola A.M., Rizzo M.R., Barbieri M., et al. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics. Neurology 2006, 67:235-240.
20. Greenwood C.E., Kaplan R.J., Hebblethwaite S., Jenkins D.J. Carbohydrate-induced memory impairment in adults with type 2 diabetes. Diabetes Care 2003, 26:1961-1966.
21. Tseng C.L., Soroka O., Maney M., et al. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA Intern Med 2014, 174:259-268.
22. Seaquist E.R., Miller M.E., Bonds D.E., et al. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care 2012, 35:409-414. ACCORD Investigators.
23. Miller M.E., Bonds D.E., Gerstein H.C., et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010, 340:b5444. ACCORD Investigators.
24. Whitmer R.A., Karter A.J., Yaffe K., et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301:1565-1572.
25. Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: A lifespan perspective. Lancet Neurol 2008, 7:184-190.
26. Feil D.G., Rajan M., Soroka O., et al. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: Implications for practice and policy. JAm Geriatr Soc 2011, 59:2263-2272.
27. Warren R.E., Frier B.M. Hypoglycaemia and cognitive function. Diabetes Obes Metab 2005, 7:493-503.
28. Risk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration. Diabetologia 2007, 50:1140-1147. UK Hypoglycaemia Study Group.